98%
921
2 minutes
20
PIP5K1α is a key member of the lipid kinase family, involved in several cellular processes including cell proliferation and differentiation, cytoskeletal remodeling, inositol-phospholipid signaling, intracellular vesicle transport, and protein secretion. Emerging evidence now highlights critical functions of PIP5K1α in asthma-related biological processes. In this review, we aim to consolidate existing literature on the involvement of PIP5K1α in asthma pathogenesis. We summarize PIP5K1α-related pathways that regulate airway immune homeostasis (regulating T cell/ILCs-mediated immune response, TLR4/MyD88/NF-κB signaling pathway, Let-7 miRNA biogenesis, and its regulatory modifications), airway hyper-responsiveness (modulating of calcium release, airway smooth muscle contractility, and epithelial barrier dysfunction), and airway remodeling (regulating cell migration, proliferation, epithelial remodeling, and cytoskeleton modulation) in asthma. Although clinically approved PIP5K1α inhibitors are currently unavailable, targeting this kinase present a compelling therapeutic strategy for asthma, requiring further research into develop effective treatments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403951 | PMC |
http://dx.doi.org/10.1186/s12967-025-06997-z | DOI Listing |
Lancet Respir Med
September 2025
Department for Paediatric Pneumology, Allergology, and Neonatology and German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease, Hannover Medical School, 30625 Hannover, Germany. Electronic address:
Stat Med
September 2025
Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia, USA.
Studying the association between mixtures of environmental exposures and health outcomes can be challenging due to issues such as correlation among the exposures and non-linearities or interactions in the exposure-response function. For this reason, one common strategy is to fit flexible nonparametric models to capture the true exposure-response surface. However, once such a model is fit, further decisions are required when it comes to summarizing the marginal and joint effects of the mixture on the outcome.
View Article and Find Full Text PDFJ Transl Med
September 2025
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
PIP5K1α is a key member of the lipid kinase family, involved in several cellular processes including cell proliferation and differentiation, cytoskeletal remodeling, inositol-phospholipid signaling, intracellular vesicle transport, and protein secretion. Emerging evidence now highlights critical functions of PIP5K1α in asthma-related biological processes. In this review, we aim to consolidate existing literature on the involvement of PIP5K1α in asthma pathogenesis.
View Article and Find Full Text PDFJ Inflamm Res
August 2025
Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, People's Republic of China.
Background: MicroRNA-491-5p (miR-491-5p) is a key regulator of cell proliferation and inflammation, but its role in asthma pathogenesis remains unclear. This study aimed to investigate the mechanistic involvement of miR-491-5p in airway remodeling and inflammation, focusing on its downstream target, B4GalT5, and oxidative stress pathways.
Methods: MicroRNA sequencing of airway smooth muscle (ASM) tissues from asthma patients revealed significant downregulation of miR-491-5p, and bioinformatic prediction combined with dual-luciferase reporter assays identified B4GalT5 as a direct downstream target.
Background Asthma remains a leading cause of ED visits among children in the United States. Despite clinical advancements, disparities in asthma care and control persist, particularly among socioeconomically and racially marginalized populations. Objective This study examines trends and sociodemographic factors associated with asthma-related ED visits in children using data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2006 to 2020.
View Article and Find Full Text PDF